Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
7000 participants
OBSERVATIONAL
2024-12-19
2026-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Quarterly Emails
Quarterly emails on performance will be sent.
No interventions assigned to this group
Control
Usual Care (no emails on performance).
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* CHADS2VASC of at least 2 in males and at least 3 in females
* Outpatient cardiology visit in past 3 months
* Most recent EF ≤40
* Age 18-90
* Outpatient cardiology visit in past 3 months
Exclusion Criteria
* Hemorrhagic Stroke
* SBP\<90
* eGFR\<30
* Potassium\>5
* Active allergy to MRA
* Acknowledge reason on heart failure alert
* Mechanical circulatory device
* Cardiac amyloid diagnosis
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amrita Mukhopadhyay, MD
Role: PRINCIPAL_INVESTIGATOR
NYU Langone Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NYU Langone Health
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QI-Specialty Ambulatory
Identifier Type: -
Identifier Source: org_study_id